Investing Profile

David Goeddel

InvestorVC

Managing Partner at The Column Group

thecolumngroup.com/member/dav...Burlingame, California
Photo of David Goeddel, Managing Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
The Column Group Managing Partner
$100K - $1M
$1M
11
CompanyStageDateRound SizeTotal Raised
Hexagon Bio
Series BSep 2021$61M
Series ASep 2020$47M
$108M
Co-investors: Millie Ray (The Column Group), Jakob Loven (Nextech Invest), Dusan Perovic (Two Sigma Ventures), Alex Kolicich (8VC)
Exonics Therapeutics
Series ANov 2017$40M
$40M
Peloton Therapeutics
Series DSep 2016$52.4M
$52.4M
NGM Biopharmaceuticals
Series DMar 2015$57.5M
$139.5M
Co-investors: Peter Svennilson (The Column Group)
Flexus Biosciences
Series BDec 2014$38M
$66.2M
Co-investors: Beth Seidenberg (Kleiner Perkins)
Nurix Therapeutics
Series BMay 2014$25.1M
Seed RoundMay 2012$3.1M
$28.2M
Igenica
Series CJan 2014$14M
Series CJun 2012$33M
$71M
Co-investors: Richard Ulevitch (5am Ventures)
Constellation Pharmaceuticals
Series CJan 2012$95M
$149.5M
Co-investors: Robert Tepper (Third Rock Ventures), Tony Evnin (Venrock), Brian Gallagher (Abingworth)